Spring House, PA (October 12, 2012) -- Clinlogix, a clinical research organization located just outside
Philadelphia, is taking steps to broaden the services they provide by bringing Julie McCusker, R.pH.
onboard as the Senior Director, Safety Services. In recent years, pharmaceutical, biotech, and medical
device companies have begun to outsource portions, or all, of their clinical trials. With this recent trend,
clinical research organizations have grown in importance as they help complete these clinical trials.
On October 1, 2012, Julie McCusker joined Clinlogix to kick-off their Safety Services. Julie is a Registered
Pharmacist with a broad and deep understanding of the biopharmaceutical and medical device
industries. She began her pharmacovigilance and medical information career over fifteen (15) years
ago at a large consumer products company. She later advanced her skills in managing drug safety
initiatives for small and large prescription drug companies and contract research organizations. This
background has more than prepared her to excel in her new position at Clinlogix.
“I am excited to be part of company with such integrity,” said Julie McCusker. “Product safety needs to
get back to its roots of exceptional data quality, with the combination of people, process and
technology. Clinlogix is poised to deliver high-quality, on time and on budget. Safety services for
devices, products and drugs are quickly changing in the safety arena. From case processing through
aggregate reporting and one-off safety projects, Clinlogix’s experienced project team, is client focused
and delivers results.”
JeanMarie Markham, President and CEO of Clinlogix, stressed the importance of the new service saying,
“As outsourcing continues to be the norm, and the proliferation of small biopharmaceutical and medical
device companies continues, it is becoming increasingly imperative for companies to have a strategic
partner that can provide a web-based safety management platform via a proven, validated technology
such as Oracle Argus to successfully meet regulatory compliance, at an affordable price point. It is not
sufficient, though to have the technology; it must be coupled with a highly skilled and proficient safety
team to maximize the effectiveness of the program.”
Clinlogix uses Oracle Argus supported by Sentrx, the industry leaders in pharmacovigilance solutions.
The safety system, coupled with our new Senior Director, Safety Services, will allow the company to
compete in a new field.
Clinlogix, a clinical research organization, provides comprehensive clinical development services for
pharmaceutical, biotech and medical device companies engaged in clinical programs. A global service
provider founded in 1999, Clinlogix supports and services clinical development of drugs, biologics,
devices and diagnostics in Discovery and Phase I through IV clinical trials, complying with worldwide
regulatory requirements. Clients choose either full-service clinical development or functional services as
they need. Certified by the Women’s Business Enterprise National Council, Clinlogix succeeds in
delivering quality and compliant results, on time and on budget. For more information, please visit
For more information about Clinlogix, or to schedule a meeting, please contact Clinlogix by email:
firstname.lastname@example.org , by phone: (215) 855-9054, or visit Clinlogix’s website: http://www.clinlogix.com/.